"#000000","#ffffff","#10222c","#287da4","#5a8128","#484848","#626262","#bbbdbf","#f69320","#f06724","#00838a","#008b93","#5cc9f3","#2a3b8f","#1b1b1b","#3e3e3e","#148e95","#008b92","#f6931f","#f06724","#2a3b8f","#282d77","#55a0d0","#3192c1","#0077a5","#1c76bc","#116bb2","#d91a5d","#b41764","#6b308d"
CMP Pharma, Inc Announces that Atorvaliq®, the First and Only FDA-approved Liquid Suspension of Atorvastatin is Now Available
CMP Pharma, Inc Announces that Liqrev®, the First and Only Ready-made FDA-approved Liquid Suspension of Sildenafil is Now Available
CMP Pharma’s Potassium Phosphates Injection Receives FDA Shelf Life Extension for Specific Lots
CMP Pharma, Inc Announces that Tadliq®, the First and Only FDA-approved Liquid Suspension of Tadalafil, is Now Available
CMP Pharma, Inc Announces that Norliqva®, the First and Only FDA-approved Liquid Solution of Amlodipine, is Now Available
CMP Pharma, Inc. Announces Unit Dose Packaging for CaroSpir®, The First and Only FDA-Approved Spironolactone Oral Suspension
First FDA approved Potassium Phosphates Injection from CMP Pharma Is Now Available
First FDA approved Potassium Phosphates Injection from CMP Pharma Has Been Approved
CMP Pharma, Inc Announces That CaroSpir®, The First And Only FDA-Approved Spironolactone Oral Suspension, Is Now Available
CMP Pharma, Inc. Announces FDA Approval of CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL)
